162 related articles for article (PubMed ID: 29958400)
1. Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study.
Zeller T; Altay A; Waldeyer C; Appelbaum S; Ojeda F; Ruhe J; Schnabel RB; Lackner KJ; Blankenberg S; Karakas M
Biomolecules; 2018 Jun; 8(3):. PubMed ID: 29958400
[TBL] [Abstract][Full Text] [Related]
2. Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study.
Weidmann H; Bannasch JH; Waldeyer C; Shrivastava A; Appelbaum S; Ojeda-Echevarria FM; Schnabel R; Lackner KJ; Blankenberg S; Zeller T; Karakas M
J Am Heart Assoc; 2020 May; 9(9):e015480. PubMed ID: 32321351
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease-First Report on the Prospective Relevance of Intrinsic Iron Release.
Ruhe J; Waldeyer C; Ojeda F; Altay A; Schnabel RB; Schäfer S; Lackner KJ; Blankenberg S; Zeller T; Karakas M
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30096922
[TBL] [Abstract][Full Text] [Related]
4. Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome.
Zeller T; Waldeyer C; Ojeda F; Schnabel RB; Schäfer S; Altay A; Lackner KJ; Anker SD; Westermann D; Blankenberg S; Karakas M
Biomolecules; 2018 Jul; 8(3):. PubMed ID: 30037035
[TBL] [Abstract][Full Text] [Related]
5. Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community.
Klip IT; Voors AA; Swinkels DW; Bakker SJ; Kootstra-Ros JE; Lam CS; van der Harst P; van Veldhuisen DJ; van der Meer P
Eur J Heart Fail; 2017 Mar; 19(3):348-356. PubMed ID: 27758018
[TBL] [Abstract][Full Text] [Related]
6. In alcoholic cirrhosis, low-serum hepcidin levels associate with poor long-term survival.
Nahon P; Nuraldeen R; Rufat P; Sutton A; Trautwein C; Strnad P
Liver Int; 2016 Feb; 36(2):185-8. PubMed ID: 26561367
[TBL] [Abstract][Full Text] [Related]
7. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload.
Fernández-Ruiz M; Parra P; Ruiz-Merlo T; López-Medrano F; San Juan R; Polanco N; González E; Andrés A; Aguado JM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29120522
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk.
An P; Wang H; Wu Q; Guo X; Wu A; Zhang Z; Zhang D; Xu X; Mao Q; Shen X; Zhang L; Xiong Z; He L; Liu Y; Min J; Zhou D; Wang F
Sci Rep; 2015 Aug; 5():13106. PubMed ID: 26290281
[TBL] [Abstract][Full Text] [Related]
9. Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus.
Pechlaner R; Weiss G; Bansal S; Mayr M; Santer P; Pallhuber B; Notdurfter M; Bonora E; Willeit J; Kiechl S
Diabetes Metab Res Rev; 2016 Feb; 32(2):187-92. PubMed ID: 26378394
[TBL] [Abstract][Full Text] [Related]
10. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study.
Sempos CT; Looker AC; Gillum RE; McGee DL; Vuong CV; Johnson CL
Ann Epidemiol; 2000 Oct; 10(7):441-8. PubMed ID: 11023623
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
13. Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.
Minchella PA; Armitage AE; Darboe B; Jallow MW; Drakesmith H; Jaye A; Prentice AM; McDermid JM
J Nutr; 2015 Jun; 145(6):1194-201. PubMed ID: 25904736
[TBL] [Abstract][Full Text] [Related]
14. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
15. Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases.
Lefebvre T; Lasocki S; Fénéant-Thibault M; Lamy PJ; Cunat S; Ropert-Bouchet M; Aguilar-Martinez P; Lehmann S; Delaby C
Ann Biol Clin (Paris); 2017 Feb; 75(1):9-18. PubMed ID: 28132948
[TBL] [Abstract][Full Text] [Related]
16. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
[TBL] [Abstract][Full Text] [Related]
18. Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
Sasai M; Iso Y; Mizukami T; Tomosugi N; Sambe T; Miyazaki A; Suzuki H
Int J Cardiol; 2017 Jan; 227():114-121. PubMed ID: 27855289
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
[TBL] [Abstract][Full Text] [Related]
20. Association of hepcidin-25 with survival after kidney transplantation.
Eisenga MF; Dullaart RP; Berger SP; Sloan JH; de Vries AP; Bakker SJ; Gaillard CA
Eur J Clin Invest; 2016 Dec; 46(12):994-1001. PubMed ID: 27696386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
